Radiopharmaceuticals Based on Somatostatin Analogs and Technetium-99m Radionuclide for Diagnosis of Neuroendocrine Tumors: a Literature Review

Introduction Somatostatin receptor imaging capabilities Radiopharmaceuticals based on somatostatin receptors agonists and technetium-99m Radiopharmaceuticals based on somatostatin receptors antagonists and technetium-99m Conclusion. © 2025, A.I. Burnazyan Federal Medical Biophysical Center. All rights reserved.

Авторы
Tishchenko V.K. , Vlasova O.P. , Ivanov S.A. , Kaprin A.D.
Журнал
Медицинская радиология и радиационная безопасность
Номер выпуска
1
Язык
Русский
Страницы
93-101
Статус
Опубликовано
Ссылка
Внешняя ссылка
DOI
10.33266/1024-6177-2025-70-1-93-101
Том
70
Год
2025
Организации
  • 1 A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Centre, Obninsk, Russian Federation
  • 2 National Medical Research Radiological Center, Moscow, Russian Federation
  • 3 Рeoples Friendship University of Russia, Moscow, Russian Federation
  • 4 P.A. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, Moscow, Russian Federation
Ключевые слова
neuroendocrine tumors; radionuclide diagnosis; radiopharmaceuticals; somatostatin analogs; technetium-99m
Цитировать
ГОСТ MLA RIS BibTex
Поделиться

Другие записи